Squarepoint
CRBU icon

Squarepoint’s Caribou Biosciences CRBU Stock Holding History

Squarepoint’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55,938
Closed -$88.9K – 4371
2025
Q4 		$88.9K Buy
55,938
+31,828
+132% +$66.8K ﹤0.01% 4054
2025
Q3 		$56.2K Sell
24,110
-5,619
-19% -$10.6K ﹤0.01% 4211
2025
Q2 		$37.5K Buy
+29,729
New +$29.2K ﹤0.01% 4345
2024
Q3 		– Sell
-68,599
Closed -$113K – 4186
2024
Q2 		$113K Sell
68,599
-101,325
-60% -$324K ﹤0.01% 3775
2024
Q1 		$873K Buy
169,924
+77,256
+83% +$476K ﹤0.01% 2687
2023
Q4 		$531K Buy
92,668
+13,723
+17% +$67.8K ﹤0.01% 2967
2023
Q3 		$377K Sell
78,945
-16,967
-18% -$105K ﹤0.01% 2993
2023
Q2 		$408K Buy
95,912
+24,334
+34% +$109K ﹤0.01% 2759
2023
Q1 		$380K Sell
71,578
-59,980
-46% -$374K ﹤0.01% 2446
2022
Q4 		$826K Buy
+131,558
New +$1.17M ﹤0.01% 1961
2022
Q3 		– Sell
-40,171
Closed -$218K – 3053
2022
Q2 		$218K Buy
+40,171
New +$307K ﹤0.01% 2431
2022
Q1 		– Sell
-76,691
Closed -$1.16M – 2926
2021
Q4 		$1.16M Buy
76,691
+1,691
+2% +$32.9K ﹤0.01% 1602
2021
Q3 		$1.79M Buy
+75,000
New +$1.83M 0.01% 1259

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Squarepoint's CRBU Position: Q1 2026 in Review

Squarepoint sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 55,938 shares — an estimated $88.9K sold.

Squarepoint first reported a position in CRBU in Q3 2021 and held it in 13 quarters. The position peaked at $1.79M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Squarepoint reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 55,938 Caribou Biosciences shares in Q1 2026, an estimated $88.9K.
  • Squarepoint first reported a position in Caribou Biosciences in Q3 2021 and held it in 13 quarters.
  • Squarepoint's Caribou Biosciences position peaked at $1.79M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.